Survival and safety of infliximab bio-original and infliximab biosimilar (CT-P13) in usual rheumatology care

Nikiphorou, E; Hannonen, P; Asikainen, J; Borodina, J; Kokko, A; Paalanen, K; Rannio, T; Sokka, T

Sokka, T (reprint author), Jyyaskyla Cent Hosp, Rheumatol Res Dept, Jyvaskyla 40620, Finland.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019; 37 (1): 55

Abstract

Objective Report to-date indicate similarity between infliximab biosimilar (IB) and infliximab bio-original (IO) in clinical efficacy and safety. This......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索